vs

Side-by-side financial comparison of FUELCELL ENERGY INC (FCEL) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.

FUELCELL ENERGY INC is the larger business by last-quarter revenue ($55.0M vs $38.3M, roughly 1.4× ImmunityBio, Inc.). FUELCELL ENERGY INC runs the higher net margin — -54.3% vs -161.8%, a 107.5% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 11.5%). FUELCELL ENERGY INC produced more free cash flow last quarter ($-23.9M vs $-71.3M).

FuelCell Energy, Inc. is a publicly traded fuel cell company headquartered in Danbury, Connecticut. It designs, manufactures, operates and services power plants based on molten carbonate fuel cells.

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

FCEL vs IBRX — Head-to-Head

Bigger by revenue
FCEL
FCEL
1.4× larger
FCEL
$55.0M
$38.3M
IBRX
Growing faster (revenue YoY)
IBRX
IBRX
+395.4% gap
IBRX
407.0%
11.5%
FCEL
Higher net margin
FCEL
FCEL
107.5% more per $
FCEL
-54.3%
-161.8%
IBRX
More free cash flow
FCEL
FCEL
$47.4M more FCF
FCEL
$-23.9M
$-71.3M
IBRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FCEL
FCEL
IBRX
IBRX
Revenue
$55.0M
$38.3M
Net Profit
$-29.9M
$-61.9M
Gross Margin
-12.1%
99.0%
Operating Margin
-51.5%
-169.0%
Net Margin
-54.3%
-161.8%
Revenue YoY
11.5%
407.0%
Net Profit YoY
27.9%
-4.7%
EPS (diluted)
$-0.43
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCEL
FCEL
IBRX
IBRX
Q4 25
$55.0M
$38.3M
Q3 25
$46.7M
$32.1M
Q2 25
$37.4M
$26.4M
Q1 25
$19.0M
$16.5M
Q4 24
$49.3M
$7.6M
Q3 24
$23.7M
$6.1M
Q2 24
$22.4M
Q1 24
$16.7M
Net Profit
FCEL
FCEL
IBRX
IBRX
Q4 25
$-29.9M
$-61.9M
Q3 25
$-91.7M
$-67.3M
Q2 25
$-38.0M
$-92.6M
Q1 25
$-28.3M
$-129.6M
Q4 24
$-41.4M
$-59.2M
Q3 24
$-32.7M
$-85.7M
Q2 24
$-32.1M
Q1 24
$-19.8M
Gross Margin
FCEL
FCEL
IBRX
IBRX
Q4 25
-12.1%
99.0%
Q3 25
-11.0%
99.4%
Q2 25
-25.2%
99.5%
Q1 25
-27.4%
99.6%
Q4 24
-22.1%
Q3 24
-26.2%
Q2 24
-31.6%
Q1 24
-70.2%
Operating Margin
FCEL
FCEL
IBRX
IBRX
Q4 25
-51.5%
-169.0%
Q3 25
-204.0%
-173.5%
Q2 25
-95.7%
-269.8%
Q1 25
-172.9%
-390.1%
Q4 24
-83.2%
-919.0%
Q3 24
-141.9%
-1314.3%
Q2 24
-184.5%
Q1 24
-254.5%
Net Margin
FCEL
FCEL
IBRX
IBRX
Q4 25
-54.3%
-161.8%
Q3 25
-196.1%
-209.8%
Q2 25
-101.7%
-350.3%
Q1 25
-149.1%
-784.9%
Q4 24
-84.0%
-783.4%
Q3 24
-137.8%
-1404.0%
Q2 24
-143.4%
Q1 24
-118.6%
EPS (diluted)
FCEL
FCEL
IBRX
IBRX
Q4 25
$-0.43
$-0.06
Q3 25
$-3.78
$-0.07
Q2 25
$-1.79
$-0.10
Q1 25
$-1.42
$-0.15
Q4 24
$-2.29
$-0.08
Q3 24
$-1.99
$-0.14
Q2 24
$-2.18
Q1 24
$-1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCEL
FCEL
IBRX
IBRX
Cash + ST InvestmentsLiquidity on hand
$278.1M
$242.8M
Total DebtLower is stronger
$103.8M
Stockholders' EquityBook value
$662.2M
$-500.5M
Total Assets
$932.1M
$501.9M
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCEL
FCEL
IBRX
IBRX
Q4 25
$278.1M
$242.8M
Q3 25
$174.7M
$257.8M
Q2 25
$177.0M
$153.7M
Q1 25
$208.4M
$61.6M
Q4 24
$257.3M
$149.8M
Q3 24
$267.2M
$130.4M
Q2 24
$260.1M
Q1 24
$297.5M
Total Debt
FCEL
FCEL
IBRX
IBRX
Q4 25
$103.8M
Q3 25
$106.4M
Q2 25
$109.4M
Q1 25
$112.3M
Q4 24
$115.7M
Q3 24
$112.7M
Q2 24
$116.2M
Q1 24
$107.2M
Stockholders' Equity
FCEL
FCEL
IBRX
IBRX
Q4 25
$662.2M
$-500.5M
Q3 25
$556.2M
$-524.3M
Q2 25
$609.2M
$-570.7M
Q1 25
$635.2M
$-591.4M
Q4 24
$656.9M
$-489.1M
Q3 24
$675.8M
$-745.1M
Q2 24
$639.8M
Q1 24
$663.9M
Total Assets
FCEL
FCEL
IBRX
IBRX
Q4 25
$932.1M
$501.9M
Q3 25
$830.5M
$519.0M
Q2 25
$883.8M
$402.1M
Q1 25
$907.5M
$303.8M
Q4 24
$944.1M
$382.9M
Q3 24
$948.9M
$364.6M
Q2 24
$916.8M
Q1 24
$923.2M
Debt / Equity
FCEL
FCEL
IBRX
IBRX
Q4 25
0.16×
Q3 25
0.19×
Q2 25
0.18×
Q1 25
0.18×
Q4 24
0.18×
Q3 24
0.17×
Q2 24
0.18×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCEL
FCEL
IBRX
IBRX
Operating Cash FlowLast quarter
$-22.9M
$-70.4M
Free Cash FlowOCF − Capex
$-23.9M
$-71.3M
FCF MarginFCF / Revenue
-43.4%
-186.2%
Capex IntensityCapex / Revenue
1.8%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-143.9M
$-308.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCEL
FCEL
IBRX
IBRX
Q4 25
$-22.9M
$-70.4M
Q3 25
$-26.8M
$-68.9M
Q2 25
$-29.9M
$-79.7M
Q1 25
$-45.7M
$-85.9M
Q4 24
$5.8M
$-85.1M
Q3 24
$-63.4M
$-98.8M
Q2 24
$-37.1M
Q1 24
$-58.3M
Free Cash Flow
FCEL
FCEL
IBRX
IBRX
Q4 25
$-23.9M
$-71.3M
Q3 25
$-32.1M
$-69.6M
Q2 25
$-35.2M
$-80.8M
Q1 25
$-52.8M
$-87.0M
Q4 24
$-4.7M
$-87.3M
Q3 24
$-76.8M
$-101.6M
Q2 24
$-50.3M
Q1 24
$-68.8M
FCF Margin
FCEL
FCEL
IBRX
IBRX
Q4 25
-43.4%
-186.2%
Q3 25
-68.6%
-217.2%
Q2 25
-94.0%
-305.9%
Q1 25
-277.8%
-526.9%
Q4 24
-9.5%
-1155.4%
Q3 24
-324.0%
-1663.2%
Q2 24
-224.5%
Q1 24
-412.4%
Capex Intensity
FCEL
FCEL
IBRX
IBRX
Q4 25
1.8%
2.4%
Q3 25
11.2%
2.3%
Q2 25
14.1%
4.1%
Q1 25
37.2%
6.8%
Q4 24
21.4%
28.0%
Q3 24
56.6%
45.7%
Q2 24
58.9%
Q1 24
63.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FCEL
FCEL

Other$30.0M55%
Electricity Generation$12.2M22%
Services$7.3M13%
Advanced Technologies$5.5M10%

IBRX
IBRX

Segment breakdown not available.

Related Comparisons